Skip to main content
main-content

Zeitschrift

Breast Cancer Research

Breast Cancer Research 1/2000

Ausgabe 1/2000

Inhaltsverzeichnis ( 60 Artikel )

01.02.2000 | Commentary | Ausgabe 1/2000

The mammary myoepithelial cell - Cinderella or ugly sister?

Sunil R Lakhani, Michael J O'Hare

01.02.2000 | Commentary | Ausgabe 1/2000

Syk: a new player in the field of breast cancer

Zoe A Stewart, Jennifer A Pietenpol

01.02.2000 | Commentary | Ausgabe 1/2000

Whither high-dose chemotherapy in breast cancer?

Astrid Mayer, Helena Earl

01.02.2000 | Commentary | Ausgabe 1/2000

BRCA1 function in T lymphocytes: a cellular specificity of a different kind

Kevin Gardner, Edison T Liu

01.02.2000 | Review | Ausgabe 1/2000

Breast imaging technology: Current and future technologies for breast cancer imaging

James P Basilion

01.02.2000 | Review | Ausgabe 1/2000

Breast imaging technology Application of magnetic resonance imaging to early detection of breast cancer

Mitchell D Schnall

01.02.2000 | Review | Ausgabe 1/2000

Breast imaging technology Application of magnetic resonance imaging to angiogenesis in breast cancer

Martin O Leach

01.02.2000 | Review | Ausgabe 1/2000

Breast imaging technology: Recent advances in imaging endogenous or transferred gene expression utilizing radionuclide technologies in living subjects: applications to breast cancer

Frank Berger, Sanjiv Sam Gambhir

01.02.2000 | Review | Ausgabe 1/2000

Imaging biochemistry: applications to breast cancer

Sabrina M Ronen, Martin O Leach

01.02.2000 | Review | Ausgabe 1/2000

Breast imaging technology: Probing physiology and molecular function using optical imaging - applications to breast cancer

Vasilis Ntziachristos, Britton Chance

01.02.2000 | Meeting report | Ausgabe 1/2000

VIII International Congress of the Metastasis Research Society

Gill Taylor, Philip Rudland

01.02.2000 | Research article | Ausgabe 1/2000 Open Access

Comparison of written reports of mammography, sonography and magnetic resonance mammography for preoperative evaluation of breast lesions, with special emphasis on magnetic resonance mammography

Sabine Malur, Susanne Wurdinger, Andreas Moritz, Wolfgang Michels, Achim Schneider

01.02.2000 | Research article | Ausgabe 1/2000 Open Access

BRCA1 and BRCA2 protein expressions in an ovotestis of a 46, XX true hermaphrodite

Dominique J Bernard-Gallon, Pierre Déchelotte, Cécile Vissac, Bénédicte Aunoble, Laetitia Cravello, Georges Malpuech, Yves-Jean Bignon

01.02.2000 | Research article | Ausgabe 1/2000 Open Access

Transforming growth factors-β are not good biomarkers of chemopreventive efficacy in a preclinical breast cancer model system

JoAnne Zujewski, Anika Vaughn-Cooke, Kathleen C Flanders, Michael A Eckhaus, Ronald A Lubet, Lalage M Wakefield

01.12.2000 | Paper Report | Ausgabe 1/2000

Marker of increased cancer risk in benign breast disease

Jenny Chang

01.12.2000 | Paper Report | Ausgabe 1/2000

Microdissection and microarrays

Mike Davies

01.12.2000 | Paper Report | Ausgabe 1/2000

Estrogen receptor β in breast cancer

Balvinder Shoker

01.12.2000 | Paper Report | Ausgabe 1/2000

Chromosome 6 alterations

Chris Jones

01.12.2000 | Paper Report | Ausgabe 1/2000

APCgene mutations in human breast cancers

Chris Jones

01.12.2000 | Paper Report | Ausgabe 1/2000

HOXA5 regulation of p53 in breast tumours

Chris Jones

01.12.2000 | Paper Report | Ausgabe 1/2000

Vaccination of breast cancer patients with MUC1 keyhole limpet hemocyanin conjugate plus QS-21

Richard de Boer

01.12.2000 | Paper Report | Ausgabe 1/2000

ER variants in breast cancer

Valerie Speirs

01.12.2000 | Paper Report | Ausgabe 1/2000

Pathologic features associated with nonsentinel lymph node metastasis

Rodolfo Laucirica

01.12.2000 | Paper Report | Ausgabe 1/2000

c-erbB2 homodimerisation in mammary epithelial cells

Jenny Gomm

01.12.2000 | Paper Report | Ausgabe 1/2000

Nuclear cytometric changes in breast carcinogenesis

Syed Mohsin

01.12.2000 | Paper Report | Ausgabe 1/2000

Tailored versus high-dose chemotherapy as adjuvant breast cancer treatment

Richard De Boer

01.12.2000 | Paper Report | Ausgabe 1/2000

Enhanced activity of anti-Lewisyhumanised 3S193 when combined with Taxol

Richard de Boer

01.12.2000 | Paper Report | Ausgabe 1/2000

Ang1 in breast cancer

Valerie Speirs

01.12.2000 | Paper Report | Ausgabe 1/2000

An anti-oncogenic role for decorin

Karen Schmeichel

01.12.2001 | Paper Report | Ausgabe 1/2000

Tamoxifen, angiogenesis, oestrogens and animal models

Valerie Speirs

01.12.2001 | Paper Report | Ausgabe 1/2000

The effect of BRK on EGF signalling via erbB3 in mammary epithelial cells

Jenny Gomm

01.12.2001 | Paper Report | Ausgabe 1/2000

Prognosis and treatment of small breast carcinomas

Frances O'Malley

01.12.2001 | Paper Report | Ausgabe 1/2000

Tissue microarray validation

Valerie Speirs

01.12.2001 | Paper Report | Ausgabe 1/2000

Normal mammary epithelial cells escape of senescence

Valerie Speirs

01.12.2001 | Paper Report | Ausgabe 1/2000

Response to CMF according to HER-2 overexpression

Richard de Boer

01.12.2001 | Paper Report | Ausgabe 1/2000

Comparison of different methods of HER-2 analysis in archival tissue

Richard de Boer

01.12.2001 | Paper Report | Ausgabe 1/2000

Liposome-encapsulated doxorubicin in metastatic breast cancer

Richard de Boer

01.12.2001 | Paper Report | Ausgabe 1/2000

Phase III trial of chemotherapy ? HerceptinR in metastatic breast cancer

Fatima Cardoso

01.12.2001 | Paper Report | Ausgabe 1/2000

Comparison of DCIS and post-surgical local recurrence

Richard de Boer

01.12.2001 | Paper Report | Ausgabe 1/2000

Nuclear-cytoplasmic shuttling of p21Cip1/WAF1is regulated by Akt

Karen L Schmeichel

01.12.2001 | Paper Report | Ausgabe 1/2000

Endocrine response: Is CGAthe key?

Valerie Speirs

01.12.2001 | Paper Report | Ausgabe 1/2000

An in vitrobreast cell immortalisation assay

Jenny Gomm

01.12.2001 | Paper Report | Ausgabe 1/2000

What do Dictyosteliumand mammary gland have in common?

Karen L Schmeichel

01.12.2001 | Paper Report | Ausgabe 1/2000

Carbonic anhydrase expression in DCIS

Rodolfo Laucirica

01.12.2001 | Paper Report | Ausgabe 1/2000

ER? expression seems important in preinvasive cancers

George Skliris

01.12.2001 | Paper Report | Ausgabe 1/2000

Duration of adjuvant tamoxifen treatment

Fatima Cardoso

01.12.2001 | Paper Report | Ausgabe 1/2000

Tamoxifen and angiogenesis

Valerie Speirs

01.12.2001 | Paper Report | Ausgabe 1/2000

Is E-cadherin/catenin axis important in grade III ductal carcinomas?

George Skliris

01.12.2001 | Paper Report | Ausgabe 1/2000

Breast cell interactions within a 3D model culture system

Jenny Gomm

01.12.2001 | Paper Report | Ausgabe 1/2000

Cyclin D1in breast cancer is not associated with Ki67 but with ER

George Skliris

01.12.2001 | Paper Report | Ausgabe 1/2000

Multigene expression patterns predict metastatic behavior

Karen L Schmeichel

01.12.2001 | Paper Report | Ausgabe 1/2000

Activin can activate p38 MAPK

Elena Neumann

01.12.2001 | Paper Report | Ausgabe 1/2000

GW5638: a new antiestrogen

Fatima Cardoso

01.12.2001 | Paper Report | Ausgabe 1/2000

Her-2/neu expression in primary breast cancer and its lymph node metastases

Fatima Cardoso

01.12.2001 | Paper Report | Ausgabe 1/2000

Her-2/neu and topoisomerase IIaexpression in primary and metastatic breast cancer

Fatima Cardoso

01.12.2001 | Paper Report | Ausgabe 1/2000

Membrane oestrogen receptor

Valerie Speirs

01.12.2001 | Paper Report | Ausgabe 1/2000

EGF receptor: new trick for an old dog?

Douglas Yee

01.12.2001 | Paper Report | Ausgabe 1/2000

Iressa inhibits growth of HER-2-overexpressing cells

Fatima Cardoso

01.12.2001 | Paper Report | Ausgabe 1/2000

Dual HER-2/EGFR tyrosine kinase inhibitors

Fatima Cardoso

01.12.2001 | Paper Report | Ausgabe 1/2000

Breast cancer protection: hormonal priming via p53?

Karen Schmeichel

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise